CRYBG1 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
T cell	17 studies	26% ± 7%	Explore
CD4-positive, alpha-beta T cell	16 studies	31% ± 10%	Explore
CD8-positive, alpha-beta T cell	15 studies	23% ± 6%	Explore
B cell	11 studies	19% ± 4%	Explore
dendritic cell	11 studies	31% ± 9%	Explore
natural killer cell	11 studies	19% ± 3%	Explore
regulatory T cell	10 studies	25% ± 10%	Explore
epithelial cell	9 studies	40% ± 21%	Explore
conventional dendritic cell	8 studies	31% ± 17%	Explore
mucosal invariant T cell	8 studies	29% ± 9%	Explore
basal cell	7 studies	35% ± 20%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	7 studies	32% ± 11%	Explore
mature NK T cell	7 studies	28% ± 12%	Explore
CD8-positive, alpha-beta memory T cell	7 studies	28% ± 8%	Explore
monocyte	6 studies	23% ± 7%	Explore
CD16-negative, CD56-bright natural killer cell, human	6 studies	22% ± 4%	Explore
classical monocyte	6 studies	24% ± 8%	Explore
non-classical monocyte	6 studies	19% ± 4%	Explore
adipocyte	6 studies	23% ± 4%	Explore
CD4-positive, alpha-beta memory T cell	6 studies	25% ± 6%	Explore
gamma-delta T cell	6 studies	25% ± 7%	Explore
memory B cell	5 studies	19% ± 2%	Explore
effector memory CD8-positive, alpha-beta T cell	5 studies	35% ± 11%	Explore
leukocyte	4 studies	23% ± 6%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	4 studies	23% ± 5%	Explore
lymphocyte	4 studies	34% ± 15%	Explore
T follicular helper cell	4 studies	27% ± 7%	Explore
CD4-positive helper T cell	4 studies	29% ± 17%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	33% ± 13%	Explore
luminal cell of prostate epithelium	4 studies	24% ± 10%	Explore
respiratory goblet cell	3 studies	21% ± 4%	Explore
effector CD8-positive, alpha-beta T cell	3 studies	21% ± 4%	Explore
placental villous trophoblast	3 studies	49% ± 8%	Explore
myeloid cell	3 studies	20% ± 3%	Explore
squamous epithelial cell	3 studies	52% ± 26%	Explore
abnormal cell	3 studies	22% ± 8%	Explore
alveolar macrophage	3 studies	24% ± 6%	Explore
CD16-positive, CD56-dim natural killer cell, human	3 studies	16% ± 0%	Explore
transit amplifying cell	3 studies	50% ± 33%	Explore
renal principal cell	3 studies	41% ± 12%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	7 studies	21% ± 5%	Explore
lung	5 studies	20% ± 4%	Explore
placenta	3 studies	23% ± 5%	Explore
intestine	3 studies	18% ± 0%	Explore
brain	3 studies	28% ± 6%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
breast	98%	4118.29	451 / 459	92%	36.23	1028 / 1118
prostate	89%	4536.44	219 / 245	100%	70.65	502 / 502
lung	93%	2599.92	538 / 578	89%	26.87	1024 / 1155
kidney	92%	2083.99	82 / 89	88%	22.09	794 / 901
intestine	67%	3332.63	652 / 966	95%	30.60	500 / 527
bladder	62%	4398.57	13 / 21	93%	26.70	468 / 504
esophagus	42%	10977.20	611 / 1445	99%	47.20	182 / 183
skin	100%	11386.50	1808 / 1809	34%	6.73	162 / 472
stomach	24%	486.69	86 / 359	91%	25.50	261 / 286
pancreas	23%	329.30	74 / 328	88%	20.21	156 / 178
thymus	38%	598.42	248 / 653	71%	8.19	432 / 605
spleen	100%	3922.06	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	98%	48.71	44 / 45
lymph node	0%	0	0 / 0	97%	21.51	28 / 29
adipose	96%	2763.02	1151 / 1204	0%	0	0 / 0
peripheral blood	94%	6606.76	872 / 929	0%	0	0 / 0
uterus	9%	246.66	15 / 170	80%	28.37	369 / 459
liver	49%	757.35	110 / 226	20%	1.97	80 / 406
ovary	2%	19.31	3 / 180	32%	3.79	137 / 430
blood vessel	11%	189.12	145 / 1335	0%	0	0 / 0
brain	0%	0	0 / 2642	8%	1.01	53 / 705
adrenal gland	0%	4.43	1 / 258	3%	0.30	8 / 230
heart	1%	11.73	7 / 861	0%	0	0 / 0
muscle	0%	4.86	2 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
eye	0%	0	0 / 0	0%	0	0 / 80
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1

III. Associated gene sets

GO_0008150	Biological process	biological_process
GO_0005575	Cellular component	cellular_component
GO_0030246	Molecular function	carbohydrate binding
GO_0003674	Molecular function	molecular_function

IV. Literature review

[source]

Gene name	CRYBG1
Protein name	Beta/gamma crystallin domain-containing protein 1 (Absent in melanoma 1 protein) AIM1 protein Crystallin beta-gamma domain containing 1
Synonyms	AIM1
Description	FUNCTION: May function as suppressor of malignant melanoma. It may exert its effects through interactions with the cytoskeleton.
Accessions	A0A0J9YWL0 ENST00000651520.1 ENST00000633556.3 Q6P5P8 A0A494C1M5 Q96QW7 ENST00000457437.1 Q9Y4K1

CRYBG1 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review